E150

E150: Israel/Gaza escalating or not? EU censorship regime, Penn donors revolt, GLP-1 hype cycle

2023-10-20 spoken.md · speaker-labeled ▶ watch ← E149 all episodes E151 →

2
ideas born
4
ideas moved
12
captures · 4 voices
4
dissenting
+90.8
conviction added
-125.9
decay · 115 silent

Every number here is replayed from score_events — the same ledger the pool ranks on. Decay is what the 115 ideas nobody mentioned gave up this week; it applies only when an episode is processed.

Tier crossings

conviction thresholds crossed by this episode — 65 / 45 / 15 · ideas born here show where they landed. why 65 isn't always green

▲ +31.6 📈 GLP-1 obesity drugs go mass-market ember watch 24.3 → 55.9
▲ +18.8 🏛️ Oct-7 derails Israel-Saudi normalization and reprices regional risk ember watch 37.0 → 55.8
▲ +27.3 🏛️ EU's Digital Services Act becomes a binding censorship and compliance regime on the platforms born at ember 27.3
▼ +13.1 📈 GLP-1 winners are priced to perfection — take the other side of the spread trade born at dormant 13.1

Kill dates that landed since E149

0 hit · 2 partial · 2 miss — windows that closed after 2023-10-13 and up to 2023-10-20, auto-scored against price data and never hand-set. verdict · R · α

ideaverdictRαclosed
📈 Amazon pivots to cash cow - the GARP re-rating PARTIAL +21.4% -1.1 2023-10-14
📈 Legacy journalism is obsolete - the opinion economy takes the audience MISS -46.8% -69.3 2023-10-14
🏦 Levered pension unwind spills into US credit MISS -7.8% -30.4 2023-10-14
📈 This drawdown is the best vintage in a decade to build and deploy PARTIAL +16.5% -6.1 2023-10-14

Who moved the board

each voice's force on conviction this episodesupports and opposes, weighted exactly as the replay applied them · share = % of this episode's movement

Chamath
Chamath
3 captures · 32% of movement · 1 idea born
+45.4 / -14.7 → net +30.7
Sacks
Sacks
2 captures · 27% of movement · 1 idea born
+51.5 → net +51.5
Jason
Jason
4 captures · 23% of movement
+19.3 / -23.7 → net -4.3
Friedberg
Friedberg
3 captures · 18% of movement
+23.3 / -10.4 → net +12.9

What got argued (4 ideas)

ordered by how hard each idea moved · quotes are verbatim from the transcript, timestamps deep-link into the episode

NVO 📈 GLP-1 obesity drugs go mass-market closed 20 ▲ +31.6 24.3 → 55.9
Friedberg
Friedberg support ×2 explicit_prediction ▶ 1:14:11
we're basically creating a new multi-billion dollar pharmaceutical drug system that people are going to have to stay on in order to stay healthy.
Jason
Jason support ×3 sentiment ▶ 1:16:38
I cycled off of it two or three times and had very minor weight gain back, three, four, or five pounds, but I deliberately changed my relationship with food, portion size, and I work out now ... I think it's an amazing wonder drug.
Chamath
Chamath support ×2 explicit_prediction ▶ 1:17:19
for many people from a health perspective, I think that it could be a really great solution. I think that these triple agonists that are coming out are going to be probably even more effective than these double agonists that we have right now.
NEW GOOGL 🏛️ EU's Digital Services Act becomes a binding censorship and compliance regime on the platforms closed 11 CONTESTED ▲ +27.3 0.0 → 27.3

The DSA hands a Brussels commission the power to define 'illegal content', order takedowns backed by fines up to 6% of global revenue, and force algorithm disclosure plus third-party data access — and Sacks and Friedberg argue the large listed platforms comply rather than fight, then export the EU standard globally the way GDPR was exported, leaving a permanent moderation, compliance and product-degradation overhang on Google and Meta. Chamath takes the direct other side: Europe is only ~25 cents of every Google revenue dollar, so a rational actor deprecates features or exits — as Meta did with news links in Canada — and the regime dies of its own cost.

plays GOOGL ·primary META evals 2024-10-20
Friedberg
Friedberg support ×3 explicit_prediction ▶ 52:50
My thoughts are that the era of the open Internet as a decentralized technology platform for the benefit of individuals and not to be overseen and run by governments is over.
Chamath
Chamath oppose ×3 explicit_prediction ▶ 57:19
if Google deprecates a bunch of features and or completely pulls out of Europe, that'll be the death knell for these kinds of decisions
Sacks
Sacks support ×3 explicit_prediction ▶ 59:00
there is a risk that these same policies get applied in the US. That is what happened with privacy. Remember, Europe went first with GDPR and then a lot of those regulations came to America.
Jason
Jason oppose ×2 sentiment ▶ 1:01:58
We don't have any insight into what kind of content they want to take down. If it's obviously abusive content, fine, but if it's, you know, COVID information or misinformation, obviously, there's going to be a problem that we saw here in the United States.
EIS 🏛️ Oct-7 derails Israel-Saudi normalization and reprices regional risk closed 15 CONTESTED ▲ +18.8 37.0 → 55.8
Sacks
Sacks support ×3 explicit_prediction ▶ 34:37
there was a process of normalization happening between Israel and a number of these Arab states, and we talked about it last week, that Jared Kushner set this in motion. There were three or four deals that were signed between Israel and the Gulf Arab states, bringing about normal relations. And Saudi Arabia was on the table as being the next one. There was a effort underway to negotiate a normalization of relations between Israel and Saudi Arabia that is now completely on ice.
Jason
Jason support ×2 explicit_prediction ▶ 35:10
And at risk of the other agreements maybe being ripped up because if Israel goes in and has a massive ground invasion and there's more suffering and death, that that will maybe blow all those accords up.
NEW LLY 📈 GLP-1 winners are priced to perfection — take the other side of the spread trade closed 11 CONTESTED ▲ +13.1 0.0 → 13.1

Chamath's read off the Morgan Stanley basket that went long the GLP-1 winners (Lilly, Novo Nordisk) and short the potentially disrupted healthcare names (Dexcom, DaVita) and returned ~80% in ten months: the market is pricing a panacea, the mechanism of action and long-term physiology are still unresolved, and no one wants to hear the bear case — so it is a bad point in the cycle to be a buyer and he would take the other side of the trade. The GLP-1 hype cycle is as overextended as the AI/NVIDIA one.

plays LLY ·primary NVO evals 2024-10-20
Chamath
Chamath support ×3 explicit_prediction ▶ 1:17:51
From an economic market perspective, I think that these things are priced to perfection. It's kind of like NVIDIA ... It's a tough point in the cycle to be a buyer, I think, as an economic actor.
Jason
Jason oppose ×2 sentiment ▶ 1:19:56
But if you're making a trade, that seems like a hard trade to make. And just to give even some more color to it, Novo Nordisk announced that it was halting its ozempic kidney disease trial early because it was so conclusive.
Friedberg
Friedberg oppose ×2 sentiment ▶ 1:20:18
I mean, remember, over 40% of Americans are clinically obese. It's sorry, almost 60% now. It's an extraordinary health epidemic in the United States. And if this drug can have this sort of an effect, it can reduce costs across the health care system.

Episode digest

written during extraction and stored in data/extractions/ep150.json — the auditable source of truth, including everything market-adjacent that did not earn a capture

Two market-relevant segments in an episode otherwise dominated by Israel/Gaza and campus politics. The EU's Digital Services Act got a full airing and split the group two-two on the part that is actually tradeable: Friedberg ('the era of the open Internet... is over') and Sacks (GDPR-style export of EU rules to the US, 'tech companies will be craven and they'll fold') see a binding global compliance and censorship overhang on Google and Meta, while Chamath argues the opposite outcome — Europe is ~25c of every Google revenue dollar, call it $60B, and if compliance costs $10-20B plus multiple compression, the rational actor deprecates features or exits like Facebook did on Canadian news links, killing the regime; Jason pushed back on all of it as unknowable until the commission defines 'illegal content'. New idea coined for that debate. The GLP-1 segment produced the one clean trade call of the week: off a Morgan Stanley long-winners/short-disrupted basket that made ~80% in ten months, Chamath said the names are 'priced to perfection... kind of like NVIDIA', a tough point in the cycle to be a buyer, and that he would take the other side — with Friedberg (60% of Americans obese, systemic cost savings) and Jason ('a hard trade to make', wonder drug) taking the bull side, so the new valuation idea is coined bearish LLY/NVO while three fresh supports also attach to E139's mass-adoption idea. On the war block, only the normalization thread is tradeable and it attaches to E149's idea: Sacks re-states the derailment thesis with receipts (the Kushner-brokered Gulf deals, Saudi 'now completely on ice', and no wider Middle East deal without resolving the Palestinian question, the two-state track having died in 2014), and Jason extends it to the existing accords being ripped up if the ground invasion happens. Deliberately NOT captured: the escalating-vs-not-escalating debate itself (Chamath 'my assessment right now is that it is not escalating' vs Sacks 'still a powder keg' vs Friedberg 'it will only escalate') is argued entirely on military and diplomatic evidence — embassies not overrun, Iran's UN press release, the Gaza invasion delay — with no claim about normalization or regional risk pricing, so it is orthogonal to the E149 thesis rather than a support or an oppose on it. Also left out: Chamath's good line that elite universities 'are essentially asset management businesses... more like BlackRock than they are like a school' amid the Penn/Harvard donor revolt, which has no listed expression.